Clinical & Translational Research Institute

Current Enrolling Studies:

Clinical research enables the medical community to bring about advances in science and health care from finding a better way to detect or control a disease or disorder to prevention and cure. By participating in clinical research studies you can impact how physicians make decisions when treating patients. The following list summarizes enrolling clinical research studies in Phoenix conducted by Abrazo Health hospitals.

Arizona Heart Hospital & Arizona Heart Institute

FFS Open-Flexible Stent - Safety and Efficacy of the FlexStent Femoropopliteal Self-Expanding Stent System in patients with Superficial Femoropoliteal Arterial Disease

CryoLife-Limbsaver - Prospective, Primary BTK Bypass Evaluation with CryoVein Cryopreserved Saphenous Vein Allograft in Patients with Critical Limb Ischemia

Chocolate-TriReme – Chocolate "BAR" - Balloon Angioplasty Registry

Pathway-JET Registry - Jetstream Navitus System Endovascular Therapy

Endoform - Prospective, multicenter clinical evaluation of the safety and effectiveness of extracellular matrix dressing in the treatment of chronic venous leg ulcers

Daiichi ePAD - Randomized, open label study of edoxaban + aspirin or clopidogrel + aspirin to maintain patency in patients with PAD following Femoropopliteal Endovascular Intervention

Baxter-Renew - Prospective, randomized, double-blind (unblinded SOC) to determine the safety and efficacy of Intramyocardialinjections of Patient’s stem cells to increase exercise capacity

JETSTREAM System - Endovascular Therapy Post-Market Registry

Medtronic Converter - Post-approval study to confirm treatment success of the Talent Converter Stent Graft with Xcelerant Hydro Delivery System used for secondary endovascular repair of infrarenal abdominal aortic or arotiliac aneurysms

Aptus-ANCHOR - Registry of HeliFX Aortic Securement System to prevent endograft migration and Type 1a endoleak, or to treat Type 1a endoleak evident at the time of implantation in patients with previously implanted commercial endografts or at the time of initial endograft impantation

Derma Sciences - A randomized, double-blind, parallel-group, vehicle and SOC controlled Phase 3 clinical trial to evaluate the efficacy and safety of DSC127 in treating non-healing fool ulcers in subjects with diabetes mellitus

Riata - Post market Lead Evaluation

A Multicenter, Open Label, Prospective, Non-Randomized - Study Of The INCRAFT™ Stent Graft System In Subjects With Abdominal Aortic Aneurysms

ST Monitoring - Detect ACS Events in ICD Patients Study (Analyze ST) Protocol #60026829/F

The CVRx Barostim HOPE4HF Study - A prospective, randomized, study describing the safety and efficacy of the Neo system in approximately 60 heartfailure subjects with a left ventricular ejection fraction ≤ 35% implanted at up to 20 US sites

The Barostim™ Hypertension Pivotal Trial - A prospective, randomized, controlled trial of up to 310 randomized subjects at up to 60 U.S. sites and up to 20 sites outside of the U.S. Subjects will be randomized in a 1:1 ratio to receive a device plus optimal medical management or to receive optimal medical management alone

The Barostim™ Hypertension Pivotal Trial - A prospective, randomized, controlled trial of up to 310 randomized subjects at up to 60 U.S. sites and up to 20 sites outside of the U.S. Subjects will be randomized in a 1:1 ratio to receive a device plus optimal medical management or to receive optimal medical management alone

Quadripolar Pacing Post Approval Study

Continued Access to PREVAIL (CAP2) - This is a prospective, non-randomized, multicenter study to provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology.

Arrowhead Hospital

ATTRACT - Acute venous thrombosis: thrombus removal with adjunctive catheter-directed thrombolysis

LAPTOP-HF - Left atrial pressure monitoring to optimize heart failure therapy

JETSTREAM System - Endovascular Therapy Post-Market Registry

Phoenix Baptist Hospital

Minerva Pivotal Study - A prospective, randomized, controlled, multi-center, clinical study to evaluate the safety and effectiveness of an Endometrial Ablation System to provide a therapeutic treatment for menorrhagia due to benign causes by ablating the endometrial lining of the uterus in premenopausal women for whom childbearing is complete

TEAM Trial - Thermablate endometrial ablation for heavy menstrual bleeding

Endoform™ - Prospective, multicenter clinical evaluation of the safety and effectiveness of extracellular matrix dressing in the treatment of chronic venous leg ulcers

Use the Form Below to Participate in Studies

First Name *
Last Name *
Email Address *
Address *
City *
State *
Zip *
Telephone
Message
* This Field is Required

 For Patients

Enroll in a Study!

For Patients

Patients interested in enrolling for a current study, please use form below and choose the correct check box.

For Physicians

Physicians interested in partnering with Abrazo Health Clinical & Translational Research Institute (CTRI), use the form below and choose the correct check box.

Find A Physician

Please select a provider or service & enter your location below.
Search By Physician